A Comparative Study of an Integrated Pharmaceutical Care Plan and a Routine Care in Bronchial Asthma
Not Applicable
Completed
- Conditions
- Bronchial Asthma
- Interventions
- Other: Pharmacist- InterventionOther: Routine Care
- Registration Number
- NCT02046759
- Lead Sponsor
- Ain Shams University
- Brief Summary
The aim of the study is to compare the effect of asthma care by clinical pharmacist intervention versus routine care on asthma control.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
- patient with clinical diagnosis of bronchial asthma
- responsible for administering their own asthma medications.
Exclusion Criteria
- patients who were not responsible for administering their own asthma medications.
- patients with cognitive defects, other pulmonary disease e.g. Chronic Obstructive Pulmonary Disease (COPD), experiencing illness with asthma-like symptoms e.g. Congestive Heart Failure, evidence of fixed airway obstruction
- patients unavailable for 2-month follow-up.
- patients who did not provide written informed consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pharmacist-Intervention Pharmacist- Intervention - Routine Care Routine Care -
- Primary Outcome Measures
Name Time Method Asthma Control Questionnaire at baseline & after 2 months of therapy
- Secondary Outcome Measures
Name Time Method Number of ER visits/ Hospitalization During 2 months of therapy Forced Expiratory Volume in 1 second (FEV1%) at baseline & after 2 months of therapy Rescue Medication SABA (number of puffs used most days) at baseline & after 2 months of therapy Inhaled Corticosteroid Use (number of puffs used/day) at baseline & after 2 months of therapy Number of courses of systemic steroid used During 2 months of therapy
Trial Locations
- Locations (1)
Ain Shams University Hospitals
🇪🇬Cairo, Egypt